Fol. Biol. 2004, 50, 175-183
https://doi.org/10.14712/fb2004050060175
Allogeneic Gene-Modified Tumour Cells in Metastatic Kidney Cancer. Report II
Crossref Cited-by Linking
- Hirbod-Mobarakeh Armin, Gordan Hesam Addin, Zahiri Zahra, Mirshahvalad Mohammad, Hosseinverdi Sima, Rini Brian I., Rezaei Nima: Specific immunotherapy in renal cancer: a systematic review. Therapeutic Advances in Urology 2017, 9, 45. <https://doi.org/10.1177/1756287216681246>
- Yoshimura Kazuhiro, Uemura Hirotsugu: Role of vaccine therapy for renal cell carcinoma in the era of targeted therapy. Int J of Urology 2013, 20, 744. <https://doi.org/10.1111/iju.12147>
- Rosenblatt Jacalyn, McDermott David F.: Immunotherapy for Renal Cell Carcinoma. Hematology/Oncology Clinics of North America 2011, 25, 793. <https://doi.org/10.1016/j.hoc.2011.04.010>
- Sfoungaristos Stavros, Giannitsas Konstantinos, Perimenis Petros: Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma. Expert Opinion on Pharmacotherapy 2011, 12, 533. <https://doi.org/10.1517/14656566.2011.524928>
- Brookman-May Sabine, Burger Maximilian, Wieland Wolf F, Rößler Wolfgang, May Matthias, Denzinger Stefan: Vaccination therapy in renal cell carcinoma: current position and future options in metastatic and localized disease. Expert Review of Vaccines 2011, 10, 837. <https://doi.org/10.1586/erv.11.64>